The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 6, 2004, Pages 509-517

  Miki, Hirohiko ^a,b   Miki, Katsuaki ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Miki Eye Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; EYE DROPS; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; RETINA; TREATMENT OUTCOME; VISUAL DISORDER; VISUAL FIELD;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BETAXOLOL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; JAPAN; MALE; OPHTHALMIC SOLUTIONS; TIME FACTORS; TIMOLOL; TREATMENT OUTCOME; VISUAL FIELDS;

EID: 10344261401     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2004.20.509     Document Type: Article

References (12)

1. Messmer, C., Flammer, J., and Stimpfig, D. Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am. J. Ophthalmol. 112:678-681, 1991.
2. Kaiser, H.J., Flammer, J., Messmer, C., Stimpfig, D., and Hendrickson, P. Thirty-month visual field follow-up of glaucoma patients treated with beta-blockers. J. Glaucoma. 1:153-155, 1992.
3. Collignon-Brach, J. Long-term effect of topical beta-blockers on intraocular pressure and visual-field sensitivity in ocular hypertension and chronic open-angle glaucoma. Surv. Ophthalmol. 38(Suppl):S149-S155, 1994.
4. Tasindi, E., and Talu, H. Differential effect of betaxolol and timolol on the progression of glaucomatous visual-field loss. In: Drance, S.M., ed. Vascular risk factors and neuroprotection in glaucoma-update 1996. New York/Amsterdam: Kugler Publications, 1997:227-234.
5. Drance, S.M. A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. J. Glaucoma. 7:247-252, 1998.
6. Harris, A., Spaeth, G.L., Sergott, R.C., Katz, L.J., Cantor, L.B., and Martin, B.J. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal tension glaucoma. Am. J. Ophthalmol. 120:168-175, 1995.
7. Harris, A., Evan, D., and Martin, B. Individual responsiveness to ocular vasodilation, vascular risk factors, and neuroprotection in glaucoma. Update 1996. Excerpta Medica 73-77, 1997.
8. Osborne, N.N., DeSantis, L., Bae, J.H., Ugarte, M., Wood, J.P., Nash, M.S., and Chidlow, G. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:331-342, 1999.
9. Yu, D.Y., Su, E.N., Cringe, S.J., Alder, V.A., Yu, P.K. and Desantis, L. Effect of betaxolol, timolol, and nimodipine on human and pig retinal arterioles. Exp. Eye Res. 67:73-81, 1998.
10. Gross, R.L., Hensley, S.H., Gao, F., and Wu, S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: Potential neuroprotective effects of beta-blockers. Surv. Ophthalmol. 43(suppl. 1):162-170, 1999.
11. Dreyer, E.B., Zurakowski, D., Schumer, R.A., Podos, S.M., and Lipton, S.A. Elevated glaucomate levels in the vitreous body of humans and monkeys with glaucoma. Eur. J. Ophthalmol. 14:299-305, 1996.
12. Turacli, M.E., Ozden, R.G., and Gurses, M.A. The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma. Eur. J. Ophthalmol. 8:62-66, 1998.